Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 138.66%2.37M | 52.23%-6.32M | -183.17%-6.14M | -213.57%-13.22M | -10.27%7.38M | -25.52%11.64M | -48.33%8.22M | 582.79%15.63M | -36.47%15.91M | -91.76%2.29M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -21.46%-3.06M | -86.53%-7.42M | -37.64%-2.52M | -138.98%-3.98M | -2,370.27%-1.83M | -514.39%-1.67M | 26.73%-74K | -6.69%-271K | -134.88%-101K | ---254K |
| Attributable subsidiary (profit) loss | ---- | 1,320.27%4.2M | --303K | --296K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | -25.31%838K | -85.94%904K | 201.61%1.12M | 1,416.04%6.43M | -59.08%372K | 215.85%424K | 778.36%909K | -267.89%-366K | -104.82%-134K | -72.89%218K |
| -Impairment of trade receivables (reversal) | -25.31%838K | -85.94%904K | 201.61%1.12M | 1,416.04%6.43M | -59.08%372K | 215.85%424K | 778.36%909K | -267.89%-366K | -104.82%-134K | -72.89%218K |
| Revaluation surplus: | 154.14%157K | 1,157.14%176K | -0.35%-290K | 101.22%14K | -63.28%-289K | -1,428.00%-1.15M | ---177K | ---75K | ---- | ---- |
| -Other fair value changes | 154.14%157K | 1,157.14%176K | -0.35%-290K | 101.22%14K | -63.28%-289K | -1,428.00%-1.15M | ---177K | ---75K | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---15K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---15K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -39.58%797K | 8.57%2.56M | 25.02%1.32M | 55.10%2.36M | 132.38%1.06M | 36.72%1.52M | -39.87%454K | 6.01%1.11M | 43.26%755K | 3.97%1.05M |
| Financial expense | -2.56%38K | -29.17%68K | -18.75%39K | 182.35%96K | 336.36%48K | 13.33%34K | -31.25%11K | 25.00%30K | 100.00%16K | -50.00%24K |
| Operating profit before the change of operating capital | 118.61%1.15M | 27.24%-5.83M | -191.43%-6.16M | -174.22%-8.01M | -27.92%6.74M | -32.79%10.79M | -43.19%9.35M | 382.95%16.06M | -41.92%16.45M | -88.79%3.33M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | 66.77%-27.34M | -351.53%-49.98M | -341.59%-82.29M | 120.29%19.87M | 6.71%-18.63M | -5,013.15%-97.92M | -243.92%-19.98M | -93.75%1.99M | -114.03%-5.81M | 154.00%31.87M |
| Accounts payable increase (decrease) | -79.16%14.28M | -4.26%45.6M | 55.11%68.53M | -75.79%47.63M | 45.18%44.18M | 9,394.24%196.76M | 388.05%30.43M | 90.52%-2.12M | 125.96%6.24M | -135.16%-22.33M |
| prepayments (increase)decrease | 1,817.31%5.75M | -244.64%-4.7M | -108.06%-335K | 317.56%3.25M | 8,092.31%4.16M | 66.51%-1.49M | 99.24%-52K | -295.82%-4.46M | -4,473.72%-6.82M | 149.07%2.28M |
| Cash from business operations | 69.57%-6.16M | -123.75%-14.9M | -155.59%-20.25M | -41.99%62.74M | 84.50%36.44M | 842.07%108.14M | 96.42%19.75M | -24.18%11.48M | -78.07%10.05M | -48.68%15.14M |
| Other taxs | -120.70%-3.13M | -73.76%-5.29M | -33.33%-1.42M | 47.81%-3.05M | 75.15%-1.07M | -449.44%-5.84M | -160.33%-4.29M | 89.07%-1.06M | 79.00%-1.65M | -108.34%-9.71M |
| Interest received - operating | 22.60%3.01M | 114.92%6.28M | 168.12%2.46M | 974.26%2.92M | 1,137.84%916K | 0.37%272K | -26.73%74K | 6.69%271K | 134.88%101K | --254K |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---16K | ---24K |
| Net cash from operations | 67.28%-6.29M | -122.22%-13.91M | -152.96%-19.22M | -38.96%62.61M | 133.55%36.29M | 859.74%102.58M | 82.94%15.54M | 88.97%10.69M | -77.68%8.49M | -77.23%5.66M |
| Cash flow from investment activities | ||||||||||
| Decrease in deposits (increase) | ---- | 202.26%46.63M | --45.6M | ---45.6M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | --15K | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -2,900.00%-90K | 95.80%-12K | 98.83%-3K | -38.83%-286K | -188.76%-257K | 35.22%-206K | 43.31%-89K | -241.94%-318K | ---157K | -111.36%-93K |
| Recovery of cash from investments | -25.00%45K | -96.00%2.34M | -99.94%60K | 157.35%58.54M | 563.17%106.53M | ---102.07M | ---23M | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | 78.05%-4.5M | ---- | ---20.5M | ---- | ---- |
| Net cash from investment operations | -100.10%-45K | 286.96%48.96M | -57.04%45.66M | 111.85%12.65M | 560.27%106.27M | -412.82%-106.76M | -14,606.37%-23.09M | -22,284.95%-20.82M | ---157K | -111.36%-93K |
| Net cash before financing | -123.95%-6.33M | -53.43%35.05M | -81.45%26.44M | 1,900.14%75.26M | 1,987.70%142.56M | 58.73%-4.18M | -190.60%-7.55M | -282.10%-10.13M | -78.09%8.34M | -77.56%5.56M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | --12.38M | ---- | ---- | --11.72M | --11.72M | ---- | ---- | ---- | ---- | --133.95M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --980K | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---242K | ---- | ---- | ---278K | ---278K | ---- | ---- | ---- | ---- | ---20.27M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | -239.84%-2.53M | ---2.62M | ---743K | ---- | ---- |
| Net cash from financing operations | 1,057.10%11.67M | -125.84%-2.38M | -111.69%-1.22M | 328.31%9.2M | 446.26%10.43M | -418.12%-4.03M | -298.28%-3.01M | -100.69%-778K | -55.24%-756K | 2,650.51%112.76M |
| Effect of rate | -342.20%-2.11M | 62.69%3.97M | -82.75%872K | -76.08%2.44M | -10.45%5.06M | 1,970.83%10.2M | 1,433.97%5.65M | 93.90%-545K | -60.98%368K | -4,087.05%-8.93M |
| Net Cash | -78.85%5.34M | -61.32%32.67M | -83.51%25.22M | 1,128.58%84.47M | 1,548.31%152.99M | 24.72%-8.21M | -239.35%-10.56M | -109.22%-10.91M | -79.82%7.58M | 480.72%118.32M |
| Begining period cash | 10.22%395.1M | 32.00%358.47M | 32.00%358.47M | 0.74%271.56M | 0.74%271.56M | -4.08%269.58M | -4.08%269.58M | 63.73%281.03M | 63.73%281.03M | 13.64%171.64M |
| Cash at the end | 3.58%398.33M | 10.22%395.1M | -10.48%384.56M | 32.00%358.47M | 62.32%429.6M | 0.74%271.56M | -8.42%264.66M | -4.08%269.58M | 37.51%288.98M | 63.73%281.03M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | --429.6M | ---- | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | --429.6M | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.